Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

48results about How to "Prevent or reduce damage" patented technology

Production method of carex meyeriana fiber

The invention discloses a production method of a carex meyeriana fiber. The production method adopts the following process flow: taking carex meyeriana raw grass, boiling, carrying out primary processing, carrying out pre-degumming treatment by an ultrasonic wave, carrying out primary washing, carrying out alkali oxidation and degumming bath, pickling, carrying out secondary washing, drying, feeding oil, opening and carding to obtain the carex meyeriana fiber, wherein water is used as a medium in the step of the pre-degumming treatment by the ultrasonic wave, when the frequency is 28-40HZ and the temperature is 50-70 DEG C, the pre-degumming treatment by the ultrasonic wave is carried out for 60-90 minutes, and NaOH is added when the treatment is carried out within 20-30 minutes so as to enable the alkali concentration of the solution to reach 5-15g / l; in the step of alkali oxidation and degumming bath process, carex meyeriana can be put in an alkali oxidation extracting solution to enable the temperature to rise to 90-100 DEG C, heat preservation and boiling are performed for 1-2 hours; the alkali oxidation extracting solution is prepared from the following ingredients: 6-9g / l of sodium hydroxide, 8-12g / l of hydrogen peroxide, 2-4% of sodium polyphosphate serving as an additive of carex meyeriana mass, 2-4% of magnesium sulfate and 1-3% of sodium sulfite.
Owner:TIANJIN POLYTECHNIC UNIV

Preserving fluid of hepatic cells for biological artificial liver and preparation method thereof

The invention provides preserving fluid of hepatic cells for a biological artificial liver and a preparation method thereof. The preserving fluid is a solution compounded by ultrapure water. The solution contains the following components within the concentration range: 15-25mmol/L of disodium hydrogen phosphate, 1-10mmol/L of sodium hydrogen phosphate dehydrate, 4-6mmol/L of potassium citrate monohydrate, 10-30mmol/L of sodium chloride, 5-10mmol/L of magnesium chloride hexahydrate, 3-10mmol/L of disodium adenosine triphosphate, 1-5mmol/L of reducing glutathione, 0.1-0.5mmol/L of alpha-lipoic acid, 100-150mmol/L of trehalose (C6H12O5), 200/0.510-50g/L of hydroxyethyl starch and 2-10mg/L of matrine. The preparation method of the preserving fluid comprises the following steps of: accurately weighing all components according to the concentration requirements of the components, wherein the alpha-lipoic acid is weighed in a dark place; completely dissolving the other components except the alpha-lipoic acid by using the right amount of ultrapure water; sufficiently dissolving the alpha-lipoic acid in the dark place; and adding the ultrapure water to full dose. The preserving fluid can well protect the cell activity of the hepatic cells for the biological artificial liver and the special functions of the hepatic cells at low temperature so as to satisfy the short-term low temperature preservation of a large-scale hepatic cell bank for the biological artificial liver and/or the hepatic cell protection in the long-distance transportation process.
Owner:ZHUJIANG HOSPITAL SOUTHERN MEDICAL UNIV

Plasmer processing device, plasmer processing method and storage medium

The invention provides a plasma processing device, a plasma processing method and storage media. In the plasma processing device using a plurality of high frequency power source to perform plasma process, when overlarge reflection waves are generated in at least one high frequency power source, output of the high frequency power source is stopped, meanwhile the output of the other high frequency power source is stopped instantly. The plurality of high frequency power sources respectively comprise: an oscillator, a communication part, an output stopping part for receiving stopping signals and stopping the output of the oscillator through the communication part, an output stopping part of at least one of the high frequency power source in the plurality of high frequency power sources monitors high frequency output from the high frequency power oscillator, the output of the oscillator is stopped in abnormity of high frequency, meanwhile, stopping signals are output to the communication part. In addition, in order to transmit the stopping signals from the monitor part to the other high frequency power source, the communication part of at least one high frequency power source and the communication part of the other high frequency power source are connected.
Owner:TOKYO ELECTRON LTD

Hydrogel containing coenzyme Q10, and cataplasm prepared by hydrogel

The present invention relates to a hydrogel containing coenzyme Q10 and a cataplasm prepared by the hydrogel. The coenzyme Q10 of the present invention is prepared into nanoparticles, solid lipid nanoparticles, flexible nano-liposomes, nano-microemulsion, nano-micelles and the like. Especially that the flexible coenzyme Q10 nano-liposomes are preferably adopted in the hydrogel of the present invention. The coenzymes Q10 with various forms are adopted to prepare the hydrogel, the cataplasm prepared by the hydrogel, and other external application preparations or apparatuses. In the prior art, the coenzyme Q10 in the common external application preparation containing the coenzyme Q10 is easily oxidized and decomposed, and is preserved difficultly. With the present invention, the problems in the prior art are effectively solved; the skin penetration performance of the coenzyme Q10 is substantially increased. The hydrogel and the cataplasm prepared by the hydrogel can be applicable for dermal topical application and nursing of the coenzyme Q10, or percutaneous systematic administration of the coenzyme Q10, specifically for preparation into cosmetics, health products, or drugs and the like. The present invention further relates to a use of the coenzyme Q10 nano-preparation in preparation of the coenzyme Q10 hydrogel preparation.
Owner:JIANGSU KANGBEIDE PHARMA

Medicament for treating ulcerative colitis

The invention provides a medicament for treating ulcerative colitis and relates to the medicament for treating colitis. The medicament is prepared by selecting the following raw materials by mass: 3 to 5g of synthetic bovine bezoar, 1.5 to 2.5g of borneol, 19 to 27g of pearl, 19 to 27g of ivory flakes, 88 to 100g of natural indigo and 13 to 19g of wall spider, grinding the raw materials are into powder, passing the power through a screen, and mixing the power to form mixed powder A; mixing 40,000 to 80,000 units of gentamicin and 30 to 50 ml of metronidazole solution to form gentamicin-metronidazole solution, and dissolving 1 percent of the mixed powder A into the gentamicin-metronidazole solution. The medicament has the advantages that: the medicament treats the ulcerative colitis and proctitis by a clysis method. The medicament can directly reach affected parts, can improve local blood concentration in intestines, avoids first-pass effect of liver, prevents or reduces damage of medicament to the liver and damage of digestive juice of stomach and intestines, and digestive enzyme to the medicament, and gives full play to availability of the medicament. The medicament also has the advantages of addressing of symptoms and root causes, rapid medicinal effect, safety, reliability and good curative effect. 156 clinical tests show that the effective rate of the medicament reaches 100 percent.
Owner:周景梅

Preparation method of rhizoma polygonati hangover-alleviating beverage

The invention relates to the technical field of hangover-alleviating beverages, in particular to a preparation method of a rhizoma polygonati hangover-alleviating beverage which comprises the following raw materials: rhizoma polygonati, milk, radix puerariae, honey, lucid ganoderma and poria cocos. The rhizoma polygonati hangover-alleviating beverage is characterized by being prepared from the following raw materials in percentage by weight according to the following process steps: S1, taking 35% of rhizoma polygonati, 35% of milk, 10% of radix puerariae, 10% of honey, 5% of lucid ganoderma and 5% of poria cocos; S2, separately boiling the rhizoma polygonati, the radix puerariae, the lucid ganoderma and the poria cocos to prepare a stock solution; and S3, mixing the rhizoma polygonati, the radix puerariae, the lucid ganoderma and the poria cocos which are boiled into the stock solution with milk and honey to prepare the rhizoma polygonati hangover-alleviating beverage. The rhizoma polygonati, the radix puerariae, the lucid ganoderma and the poria cocos are mixed with the milk and the honey to prepare the rhizoma polygonati hangover-alleviating beverage, so that the rhizoma polygonati hangover-alleviating beverage can be more conveniently drunk before or after drinking, the protection on a human body is effectively improved, and the hangover-alleviating effect is improved.
Owner:池州市正红农业有限公司

Umbilical cord mesenchymal stem cell protein-free non-programmed freezing medium and preparation method thereof

The invention relates to the technical field of stem cell culture, in particular to a protein-free non-programmed freezing medium for umbilical cord mesenchymal stem cells as well as a preparation method and application of the protein-free non-programmed freezing medium. The cryopreservation solution comprises a basic solution, a nutritional supplement, a permeable protective agent, a non-permeable protective agent, a cell sedimentation stabilizer, a cell membrane protective agent, an apoptosis inhibitor and an antioxidant, the basic solution is DMEM / F-12 with the glucose content being smaller than or equal to 1000 mg / L. The cryopreservation liquid is suitable for directly cryopreserving umbilical cord mesenchymal stem cells at-80 DEG C after in-vitro amplification and before stem cell treatment. The cryopreservation liquid is free of serum and protein and clear in chemical component, and the cryopreserved umbilical cord mesenchymal stem cells are free of exogenous pollution risk and safer to use; after the cells are recovered, the viability is high, the adherence rate is high, and the cell expansion is fast; surface marker characteristics (phenotypes) and three-line differentiation potential of the mesenchymal stem cells can be maintained; optimization is carried out according to the cryopreservation and culture characteristics of the umbilical cord mesenchymal stem cells, the cryopreservation effect is improved, programmed cooling is not needed, and time and labor are saved.
Owner:大连博格林生物科技有限公司

Printing material container, and board mounted on printing material container

A printing material container is detachably attachable to a printing apparatus having a plurality of apparatus-side terminals. The printing material container comprises a first device, a second device, and a terminal group that includes a plurality of first terminals, at least one second terminal and at least one third terminal. The plurality of first terminals are connected to the first device and respectively include a first contact portion for contacting a corresponding terminal among the plurality of apparatus-side terminals. The at least one second terminal is connected to the second device and includes a second contact portion for contacting a corresponding terminal among the plurality of apparatus-side terminals. The at least one third terminal is for the detection of shorting between the at least one second terminal and the at least one third terminal and includes a third contact portion for contacting a corresponding terminal among the plurality of apparatus-side terminals. The at least one second contact portion, the plurality of the first contact portions, and the at least one third contact portion are arranged so as to form one or multiple rows. The at least one secondcontact portion is arranged at an end of one row among the one or multiple rows.
Owner:SEIKO EPSON CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products